KAWASAKI DISEASE
Adam Z. Barkin
BASICS
DESCRIPTION
- Acute inflammatory process involving multiple organs
- Leading cause of childhood-acquired heart disease in developed countries
- Vasculitis is most severe in medium-sized arteries
- Acute cardiac sequelae:
- Coronary artery aneurysm:
- Often lead to stenosis after healing
- Giant aneurysm:
- Myocarditis
- Pericarditis
- Stages:
- Acute (lasts 1–2 wk):
- Fever
- Oral mucosal erythema
- Conjunctival injection
- Erythema and edema of hands and feet
- Cervical adenopathy
- Aseptic meningitis
- Hepatic dysfunction
- Diarrhea
- Myocarditis
- Pericardial effusion (20–40%)
- No aneurysms by ECHO
- Subacute (when fever, rash, and lymphadenopathy resolve until about 4 wk):
- Anorexia
- Irritability
- Desquamation of hands and feet
- Thrombocytosis
- Coronary artery aneurysms (20% if untreated)
- Risk for sudden death is highest
- Convalescent phase (about 6–8 wk):
- Clinical signs are absent
- ESR normalizes
- Epidemiology:
- 80% of cases occur in children <4 yr old; peak at 1–2 yr; rare in infants <3 mo old
- Adult cases have been reported
- Asians are at highest risk
- Males > females 1.5:1
- Genetics:
- Possible genetic predisposition
- Risks for nonresponse to standard therapy (10–15%):
- Elevated band count
- Low albumin level
- Abnormal initial ECHO
- Risks for development of coronary artery aneurysms:
- Extremes of age
- Male gender
- Prolonged fever
- Persistent fever after treatment
- Delay in diagnosis
- Increased WBC and/or band count
- Low hematocrit
- Significant increase in CRP and/or ESR
ETIOLOGY
- Unknown—believed to be infectious based on manifestations of disease, epidemics, and increased numbers of cases in winter and early spring
- Current theory:
- Activation of immune system in response to infection
- Genetically susceptible host
- May explain why certain ethnicities have higher incidence of disease
- More prominent in Asian countries
DIAGNOSIS
- Classic diagnostic criteria:
- Fever for 5 days + 4 of the 5 following criteria:
- Bilateral conjunctival injection
- Changes in oral mucosa
- Polymorphous erythematous rash
- Changes in hands or feet—edema, erythema, desquamation
- Cervical lymphadenopathy >1.5 cm (least common)
- Atypical cases can be seen without meeting diagnostic criteria
- Fever for >5 days + 2 or 3 clinical criteria with ESR >40 and CRP >3
- If >3 of the below can diagnose incomplete Kawasaki disease
- Albumin <3
- Anemia for age
- ALT elevation
- WBC > 15,000
- Urine >10 WBC per high power field
- Platelets >450,000 after 7 days
- Thrombocytosis
- Changes in hands or feet—edema, erythema, desquamation
- Cervical lymphadenopathy >1.5 cm (least common)
SIGNS AND SYMPTOMS
History
- Temperature >38.5°C (often spiking) for at least 5 days:
- Begins abruptly and may last >2 wk
- Cardiac:
- Shortness of breath
- Chest pain
- HEENT:
- Eyes:
- Conjunctivitis
- Photophobia
- Mouth:
- Erythema
- Dry and fissured lips
- Skin rash
- Musculoskeletal:
- Neurologic:
- GI:
- Diarrhea
- Vomiting
- Abdominal pain
Physical-Exam
- Cardiac:
- Evidence of congestive heart failure
- Evidence of pericarditis
- Evidence of valvular disease
- HEENT:
- Eyes:
- Bilateral conjunctival injection without exudates
- Bulbar conjunctiva is more frequently involved than palpebral conjunctiva
- Usually within 2 days of onset of fever and lasting 1–2 wk
- Photophobia, uveitis, iritis
- Mouth:
- Erythema, dry and fissured lips, strawberry tongue, pharyngeal erythema
- Lymph:
- Cervical lymphadenopathy (node diameter >1.5 cm)
- Neurologic:
- Skin:
- Rash, primarily on the trunk
- May be maculopapular, scarlatiniform, or erythema multiforme–like; erythroderma
- Changes in the hands or feet—erythema, edema (acute phase); unwilling to bear weight
- Desquamation (subacute phase) of the tips of fingers and toes 2–3 wk after onset of illness
- Genitourinary:
- GI:
- Hydrops of the gallbladder
ESSENTIAL WORKUP
Must think of the diagnosis in a febrile child with rash
DIAGNOSIS TESTS & NTERPRETATION
Lab
- CBC:
- WBC—normally elevated with shift to left in acute phase
- Normocytic anemia
- Leukopenia and thrombocytopenia are rare
- Suspect viral infection
- Thrombocytopenia is a risk factor for development of coronary artery disease
- Urinalysis:
- Sterile pyuria
- Proteinuria
- ESR elevated from 1st wk until 4–6 wk
- Increased C-reactive protein
- CSF pleocytosis
- Cultures: Negative blood, urine, CSF, throat
- Increased transaminases and bilirubin
Imaging
- ECHO to evaluate for coronary artery aneurysm:
- Acute phase (baseline)
- 2–3 wk
- 6–8 wk
- CXR
Diagnostic Procedures/Surgery
- ECG if concern about MI or pericarditis
- Slit-lamp exam—uveitis
DIFFERENTIAL DIAGNOSIS
- Viral infections:
- Adenovirus
- Enterovirus
- Measles
- Epstein–Barr virus
- Rubella
- Rubeola
- Influenza
- Bacterial infection:
- Scarlet fever (responds rapidly to penicillin)
- Staphylococcal scalded-skin syndrome
- Rickettsial disease, including Rocky Mountain Spotted Fever and leptospirosis
- Cervical adenitis
- Immune-mediated:
- Stevens–Johnson syndrome
- Erythema multiforme
- Serum sickness
- Connective tissue disease (i.e., Lupus)
- Other forms of vasculitis
TREATMENT
PRE HOSPITAL
INITIAL STABILIZATION/THERAPY
ABCs with focus on cardiovascular system
ED TREATMENT/PROCEDURES
- Initiate IV gammaglobulin (IVIG) and aspirin therapy:
- Do not generally need to monitor salicylate levels because of decreased absorption and increased clearance
- Treatment within the 1st 10 days of illness reduces cardiac sequelae from range of 20–25% to range of 2–4%.
- Cardiology consultation
- Treatment of MIs as in adults
MEDICATION
First Line
- IVIG: 2 g/kg IV over 10–12 hr; retreatment may be required for persistent (>48–72 hr) or recrudescent fever:
- Requires close cardiac monitoring
- Should be started within the 1st 10 days of illness
- 3–4% failure rate after 2 doses
- Aspirin: 80–100 mg/kg/d PO q6h until about day 14 when fever has resolved; then 3–5 mg/kg/d PO daily for 6–8 wk. Do not exceed 4g/24 h (peds: Do not exceed 120 mg/kg/24 h):
- Anti-inflammatory
- Antiplatelet
- Potentiates the action of IVIG
- Reduces the occurrence of aneurysms when given with IVIG
- Alternative dosing at 30 mg/kg/d during acute and subacute phases
Second Line
If no response to 2nd dose of IVIG
- Corticosteroids:
- Methylprednisolone 30 mg/kg over 3 hr
- May improve outcome in conjunction with IVIG